We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
More than 60 rare-disease drugs have been approved for marketing in China, of which over 40 are included in the national medical insurance system, according to official data.